Biotech · Private company
La Jolla Pharmaceutical Company
Track this companyFree. Adds La Jolla Pharmaceutical Company to your Dealase workspace and tells you when its record changes.
Clinical trials92 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- LJPC-401Phase 2 · Beta-ThalassemiaClinicalTrials.gov · fetched Nov 12, 2026
- LJPC-401Phase 2 · Hereditary HemochromatosisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- ANG-First Trial (Angiotensin II as First-Line Vasopressor Therapy in Cardiac Surgery)PHASE4 · RECRUITING · started May 6, 2025ClinicalTrials.gov NCT06487585 · fetched Nov 12, 2026
- Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic ShockPHASE4 · UNKNOWN · started Dec 4, 2023ClinicalTrials.gov NCT06122987 · fetched Nov 12, 2026
- Serum Biomarkers to Predict Response to Angiotensin II in Septic ShockPHASE4 · COMPLETED · started Apr 17, 2023ClinicalTrials.gov NCT05824767 · fetched Nov 12, 2026
- Angiotensin II in Liver TransplantationPHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Jun 28, 2022ClinicalTrials.gov NCT04901169 · fetched Nov 12, 2026
- Angiotensin II for Distributive ShockPHASE4 · TERMINATED · started Jun 1, 2022ClinicalTrials.gov NCT04904562 · fetched Nov 12, 2026
- Angiotensin II vs. Vasopressin in Septic ShockPHASE4 · WITHDRAWN · started Jan 3, 2022ClinicalTrials.gov NCT05193370 · fetched Nov 12, 2026
- Angiotensin II in the Perioperative Management of Hypotension in Kidney Transplant RecipientsPHASE4 · COMPLETED · started Aug 13, 2020ClinicalTrials.gov NCT04529005 · fetched Nov 12, 2026
- A Study With LJPC-401 for the Treatment of Myocardial Iron Overload in Patients With Transfusion-Dependent Beta ThalassemiaPHASE2 · TERMINATED · started Nov 30, 2017ClinicalTrials.gov NCT03381833 · fetched Nov 12, 2026
- A Study of LJPC-401 for the Treatment of Iron Overload in Adult Patients With Hereditary HemochromatosisPHASE2 · COMPLETED · started Nov 29, 2017ClinicalTrials.gov NCT03395704 · fetched Nov 12, 2026